Bridging INTERMACS 1 patients from VA-ECMO to LVAD via Impella 5.0: De-escalate and ambulate

Keebler, 2018, Venoarterial extracorporeal membrane oxygenation in cardiogenic shock, JACC Heart Fail, 6, 503, 10.1016/j.jchf.2017.11.017

Pappalardo, 2017, Concomitant implantation of Impella® on top of veno–arterial extracorporeal membrane oxygenation may improve survival of patients with cardiogenic shock, Eur J Heart Fail, 19, 404, 10.1002/ejhf.668

Patel, 2018, Simultaneous venoarterial extracorporeal membrane oxygenation and percutaneous left ventricular decompression therapy with Impella is associated with improved outcomes in refractory cardiogenic shock, ASAIO J, 17

Alba, 2007, Usefulness of the INTERMACS scale to predict outcomes after mechanical assist device implantation, J Heart Lung Transplant, 28, 827, 10.1016/j.healun.2009.04.033

Palak, 2016, Clinical outcomes of advanced heart failure patients with cardiogenic shock treated with temporary circulatory support before durable LVAD implant, ASAIO J, 62, 20, 10.1097/MAT.0000000000000309

Bansal, 2016, Using the minimally invasive Impella 5.0 via the right subclavian artery cutdown for acute on chronic decompensated heart failure as a bridge to decision, Ochsner J, 16, 210

Marasco, 2016, Extracorporeal life support bridge to ventricular assist device : the double bridge strategy, Artif Organs, 40, 100, 10.1111/aor.12496

Tarzia, 2015, Extracorporeal life support in cardiogenic shock: impact of acute versus chronic etiology on outcome, J Thorac Cardiovasc Surg, 150, 333, 10.1016/j.jtcvs.2015.02.043

Soliman, 2018, Circulation., 137, 891, 10.1161/CIRCULATIONAHA.117.030543

Kiernan, 2017, Early right ventricular assist device use in patients undergoing continuous-flow left ventricular assist device implantation: incidence and risk factors from the interagency registry for mechanically assisted circulatory support, Circ Heart Fail, 10.1161/CIRCHEARTFAILURE.117.003863

Toda, 2018, Role of percutaneous veno-arterial extracorporeal membrane oxygenation as bridge to left ventricular assist device, J Artif Organs, 21, 39, 10.1007/s10047-017-0984-3

Cheng, 2016, Device strategies for patients in INTERMACS profiles 1 and 2 cardiogenic shock : double bridge with extracorporeal membrane oxygenation and initial implant of more durable devices, Artif Organs, 41, 224, 10.1111/aor.12758

Schibilsky, 2015, Impella 5.0 support in INTERMACS II cardiogenic shock patients using right and left axillary artery access, Artif Organs, 39, 660, 10.1111/aor.12529

Esposito, 2018, Maximum level of mobility with axillary deployment of the Impella 5.0 is associated with improved survival, IJAO Int J Artif Organs, 41, 236, 10.1177/0391398817752575